[Türkçe] | |
Turkish Society of Cardiology Young Cardiologists Bulletin Year: 5 Number: 6 / 2022 |
|
Reviewer: Dr. İbrahim Halil Özdemir Name of the Study: Evening dosing of blood pressure medication not better than morning dosing: TIME trial Published Congress: ESC 2022 Background: High blood pressure is an important cause of mortality and morbidity worldwide. Recent studies have shown that night-time blood pressure affects cardiovascular outcomes more than morning time blood pressure, and antihypertensive medication taken in the evening provides a greater reduction in blood pressure. However, the best treatment option in this regard is still unknown. Objective: The aim of this study was to investigate whether the evening dose of antihypertensive drugs improves major cardiovascular outcomes compared to the morning dose. Methods: Patients with a valid e-mail address and taking at least one antihypertensive drug were included in the study. Participants were randomized 1:1 according to their morning or evening antihypertensive medication after registering on the TIME website (http://www.timestudy.co.uk). The primary endpoint of the study was cardiovascular mortality and morbidity. Results: Of a total of 21,104 patients, 10,503 were randomized to the evening dose and 10,601 to the morning dose. The primary endpoint occurred in 362 (3.4%) (0.69 events 100 patients/year) participants in the evening medication group and 390 (3.7%) (0.72 events 100 patients/year) participants in the morning medication group [hazard ratio (HR) 0.95, 95% confidence interval (CI) 0.83–1.10; p=0.53]. Conclusion: No superiority of evening dose of antihypertensive drug over morning dose was demonstrated. Interpretations: The TIME study showed that taking the antihypertensive drug in the evening or in the morning had no effect on cardiovascular mortality and morbidity. People with high blood pressure should take their antihypertensive treatment regularly and at the most convenient time of the day. |
2025 © Turkish Society of Cardiology. |